What’s new in antimicrobial use and resistance in critically ill patients?

Author： Bassetti Matteo   Nicolau David   Calandra Thierry  

Publisher： Springer Publishing Company

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.40, Iss.3, 2014-03, pp. : 422-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Levetiracetam use in critically ill patients

By Szaflarski Jerzy   Meckler Jason   Szaflarski Magdalena   Shutter Lori   Privitera Michael   Yates Stephen  

Neurocritical Care, Vol. 7, Iss. 2, 2007-10 ,pp. : 140-147

Humana Press, Inc

Access to resources Recommend Favorite

What can be expected from antimicrobial de-escalation in the critically ill?

By Kollef Marin  

Intensive Care Medicine, Vol. 40, Iss. 1, 2014-01 ,pp. : 92-95

Springer Publishing Company

Access to resources Recommend Favorite

New regulations for the care of the critically ill patients in Italy

By Zamperetti Nereo   Conti Giorgio  

Intensive Care Medicine, Vol. 30, Iss. 8, 2004-08 ,pp. : 1660-1661

Springer Publishing Company

Access to resources Recommend Favorite

Clopidogrel in Critically Ill Patients

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 217-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 774-779

John Wiley & Sons Inc

Access to resources Recommend Favorite